Infants with gestational age < 30 weeks were randomized to receive an AgION impregnated or non-impregnated polyurethane umbilical venous catheter (UVC). The primary endpoint was the incidence of CRBSIs during the time the UVC was in place.
We studied 86 infants, 41 of whom received the AgION catheter and 45 the non-impregnated catheter. During umbilical venous catheterization 2 % of infants in the AgION group developed CRBSI in comparison with 22 % of infants in the control group (p = 0.005). AgION catheters were well tolerated and none of the patients showed signs attributable to silver toxicity.
The AgION-impregnated UVCs were effective in decreasing the development of CRBSIs in preterm infants compared to non-impregnated polyurethane UVCs.